Cyclacel Plunges 11.09% on Revenue Guidance Cut

On July 21, 2025, Cyclacel's stock price dropped by 11.09% in pre-market trading.

Cyclacel Pharmaceuticals, Inc. has seen significant volatility in its stock price, with a one-year low of $3.08 and a one-year high of $597.60. This wide range indicates the speculative nature of the stock, which can be influenced by various factors including market sentiment and company-specific news.

The company's short interest ratio is relatively low, with 1,300 shares shorted, representing 0.08% of the float. This suggests that there is not a significant amount of bearish sentiment among investors, which could be a positive sign for the stock's stability.

Cyclacel's stock price has been influenced by updates to its revenue guidance for the fiscal year 2025. The company's decision to adjust its revenue projections has led to a decline in its stock price, reflecting investor concerns about the company's financial performance.